Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2-3 years treatment with tamoxifen in Sweden.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples